Press review archive 2020
On this page, you can find all the press review of 2020
2020 – October 12
ITALFARMACO
Italfarmaco Receives FDA Rare Pediatric Disease Designation for Givinostat in Duchenne Muscular Dystrophy…
2020 – April 27
Business Wire
Italfarmaco Provides Update on Advanced-Stage Clinical Development Program with Givinostat in Duchenne Muscular Dystrophy